Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Ischemic Stroke peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Ischemic Stroke. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
3 profiles.
2013–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 164 selected PubMed records and 20 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Ischemic Stroke unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00868283
PeptideScanner retained ClinicalTrials.gov record NCT00868283 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-12-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 15, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07846488
PeptideScanner retained ClinicalTrials.gov record NCT07846488 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 29, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00061373
PeptideScanner retained ClinicalTrials.gov record NCT00061373 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-02-04, and PeptideScanner's reviewed identity mapping was eptifibatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 4, 2013
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Cerebrolysin · 2026-09-29
ClinicalTrials.gov record NCT07846488
Not yet recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-09-24
ClinicalTrials.gov record NCT07511543
Not yet recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2023-12-15
ClinicalTrials.gov record NCT00868283
Completed at the retained observation.
Open attributed record →Eptifibatide · 2014-04-17
ClinicalTrials.gov record NCT00894803
Completed at the retained observation.
Open attributed record →Eptifibatide · 2013-02-04
ClinicalTrials.gov record NCT00061373
Completed at the retained observation.
Open attributed record →